Acta Scientific Microbiology (ISSN: 2581-3226)

Research Article Volume 6 Issue 3

In-house Assembled Protective Devices in Laboratory Safety in Clinical Biochemistry Laboratory of a COVID-19 Dedicated Hospital

Abhishek Dubey1, Aastha Bansal1, Subash Chandra Sonkar2, Binita Goswami1, Naina Makwane1, Vikas Manchanda3 and Bidhan Chandra Koner1*

1Department of Biochemistry, Maulana Azad Medical College and Associated Hospitals, New Delhi, India

2Multidisciplinary Research Unit (MRU), Maulana Azad Medical College and Associated Hospitals, New Delhi, India

3Department of Microbiology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India

*Corresponding Author: Bidhan Chandra Koner, Director Professor and Head, Department of Biochemistry, Maulana Azad Medical College and Associated Hospitals, New Delhi, India.

Received: January 24, 2023; Published: February 21, 2023

Abstract

Staff of diagnostic laboratory handling COVID positive samples is at risk and need to take recommended protective measures. Many protective materials were not available in diagnostic laboratories in India when the pandemic reached the country before it was prepared adequately, forcing laboratory managers to take innovative measures to protect the laboratory personnel. In this study, we have evaluated the effect of standard operating procedure (SOP) using innovative protective devices such as face shield made from OHP sheets and cardboard boxes fitted with hypochlorite spraying device as alternative to biosafety cabinet on contamination of laboratory surfaces and rate of infection among laboratory staff with virus causing COVID-19. These were used for 14 days along with other routine safety measures like use of gloves, surgical masks, OT gowns etc. before PPE and biosafety cabinet were made available in Clinical biochemistry lab of a dedicated COVID hospital in the national capital region of Delhi, India. Laboratory technicians, residents and nursing orderlies posted in clinical biochemistry laboratory were checked regularly for signs and symptoms of COVID 19 during these 14 days and tested for virus causing COVID 19 from their nasal and throat swab by RT-PCR on 14th day. The laboratory surface, by taking swab from multiple sites, was checked on 14th day for above-mentioned virus by RT-PCR. The COVID test report was negative for the staff members (n = 10) and no surface contamination was detected. Innovative and cost effective protective devices can be built in-house with locally available resources and are effective in preventing the spread of COVID 19 among the staff working in clinical biochemistry laboratory. Laboratory managers in resource scarce areas need to be innovative to face such sudden challenges like COVID-19 pandemic.

Keywords: COVID-19; SARS-CoV 2; Biosafety; Laboratory Safety; Clinical Biochemistry Laboratory; Developing Country

References

  1. Zhu H., et al. “The novel coronavirus outbreak in Wuhan, China”. Global Health Research and Policy 5 (2020): 6.
  2. Kocatepe V., et al. “Fear of COVID-19 and its influence on palliative care patients”. International Journal of Palliative Nursing 1 (2023): 28-33.
  3. Sim MR. “The COVID-19 pandemic: major risks to healthcare and other workers on the front line”. Occupational and Environmental Medicine 77 (2020): 281-282.
  4. Bowdle A and Munoz-Price LS. “Preventing infection of patients and healthcare workers should be the new normal in the era of novel coronavirus epidemics”. Anesthesiology6 (2020): 1292-1295.
  5. Wang W., et al. “Detection of SARS-CoV-2 in Different Types of Clinical Specimens”. JAMA18 (2020): 1843-1844.
  6. Garg S., et al. “Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection”. Clinica Chimica Acta 527 (2021): 11-16.
  7. Huang I., et al. “C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis”. Therapeutic Advances in Respiratory Disease 14 (2020): 1753466620937175.
  8. Dubey A., et al. “Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital”. Journal of Medical Virology9 (2021): 5339-5349.
  9. Wadhawan S., et al. “The Challenges During the COVID-19 Waves in India – from an Intensivists Experience". Acta Scientific Microbiology3 (2023): 35-40.
  10. Belluco S., et al. “Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis”. European Journal of Epidemiology7 (2021): 685-707.
  11. Dubey A., et al. “Inhouse assembled protective devices in laboratory safety against SARS-nCoV-2 in clinical biochemistry laboratory of a COVID dedicated hospital”. medRxiv (2020): 2020.08.24.20155713.
  12. Boone SA and Gerba CP. “Significance of Fomites in the Spread of Respiratory and Enteric Viral Disease”. Applied and Environmental Microbiology6 (2007): 1687-1696.
  13. Galbadage T., et al. “Does COVID-19 Spread Through Droplets Alone?” Frontiers in Public Health 8 (2020): 163.
  14. Rutter DA, EVANS CGT. “Aerosol hazards from some clinical laboratory apparatus”. BMJ 1 (1972): 594-597.
  15. Güner R., et al. “COVID-19: Prevention and control measures in community”. Turkish Journal of Medical Sciences 50 (2020): 571-577.
  16. Lippi G., et al. “Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations”. CCLM (2020).
  17. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance
  18. https://www.maggenome.com/shop/rna-extraction-saliva-cellline-kit/
  19. Lu R., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”. Lancet (2020): S0140-6736 (20)30251-8.
  20. Chan JF., et al. “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster”. Lancet 10223 (2020): 514‐523.
  21. Corman VM., et al. “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR”. Euro Surveillance3 (2020): 2000045.
  22. Yam WC., et al. “Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus”. Journal of Clinical Microbiology10 (2003): 4521‐4524.
  23. Mahilkar S., et al. “SARS-CoV-2 variants: Impact on biological and clinical outcome”. Frontiers in Medicine 9 (2022): 995960.
  24. Irungbam M., et al. “Evaluation of Performance of Detection of Immunoglobulin G and Immunoglobulin M Antibody Against Spike Protein of SARS-CoV-2 by a Rapid Kit in a Real-Life Hospital Setting”. Frontiers in Microbiology 13 (2022): 802292.
  25. Parihar S M., et al. “The Idea of Geospatial Gender-Based Data Infrastructure for Protecting Women Living in Post Covid-19 Created Global Village”. Advances in Social Sciences Research Journal10 (2022): 148-153.
  26. Soni VK., et al. “Curcumin, a traditional spice component, can hold the promise against COVID-19?” European Journal of Pharmacology 886 (2020): 173551.
  27. Gupta A., et al. “Positive QuantiFERON test and the severity of COVID-19 disease: A prospective study”. Indian Journal of Tuberculosis4 (2021): 474-480.

Citation

Citation: Bidhan Chandra Koner., et al. “In-house Assembled Protective Devices in Laboratory Safety in Clinical Biochemistry Laboratory of a COVID-19 Dedicated Hospital". Acta Scientific Microbiology 6.3 (2023): 75-82.

Copyright

Copyright: © 2022 Bidhan Chandra Koner., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


Contact US